Independent Randomized Clinical Trial in Carotid Revascularization with MicroNet Covered Stent (CGuard) Comparing Early Neurological Outcomes with distal EPS Versus Proximal EPS. The SIBERIA II Trial

Description of the study: Multicenter Randomized  clinical trial with two intervention arms. The SIBERIA study demonstrated a clear advantage of CGuard stent implantation over the existing classical stent when using a distal anti-embolic device. At the same time, there is no Level 1 evidence for a difference between the proximal and distal anti-embolic device for the CGuard stent.

The main objective of this randomized control Study is to compare distal EPS versus proximal EPS in the incidence of  New DW-MRI lesions post-procedural  24-48h  and  Death, Stroke, and Myocardial Infarction (DSMI) at Procedural, 48h, and 30 days